INVESTIGATOR SITE SELECTION SERVICES IN INDIA
Overview of the Indian Clinical Trials Market
The Indian clinical trials market is rapidly expanding, making it an attractive destination for global pharmaceutical companies. With a market size of over $1.5 billion and an annual growth rate exceeding 12%, India stands out due to its cost-effective solutions, high-quality research infrastructure, and a large, diverse patient population.
Market Size and Value
- Market Size: Over $1.5 billion
- Annual Growth Rate: >12%
Number of Investigator Sites
According to the Clinical Trials Registry - India (CTRI), there are over 3,000 registered investigator sites across the country. These sites are strategically distributed to leverage the diverse patient populations and regional expertise available throughout India.
Regional Distribution of Investigator Sites
- North India: 800+ sites
- South India: 900+ sites
- East India: 600+ sites
- West India: 700+ sites
This regional distribution ensures that clinical trials can access varied patient demographics and medical expertise, enhancing the generalizability and success rates of clinical studies.
Why Choose Independent Services for Investigator Site Selection?
Objective and Unbiased Assessment: Relying on a single CRO for site selection can lead to biased assessments due to potential conflicts of interest. Our independent consultancy provides an unbiased evaluation, ensuring that the selected sites are genuinely the best fit for your clinical trial requirements.
Comprehensive Site Evaluation: Our service includes a thorough evaluation of potential investigator sites, covering:
- Infrastructure: Analysis of facilities, equipment, and technology to ensure they meet trial requirements.
- Staff Expertise: Review of site staff qualifications, experience, and training in clinical trial conduct.
- Patient Population: Assessment of patient demographics and recruitment capabilities.
Regulatory and Compliance Assurance: Navigating the regulatory landscape in India can be complex. We ensure that all potential sites comply with local and international regulatory standards, including:
- Regulatory Approvals: Verification of site compliance with relevant regulatory bodies (e.g., DCGI, ICMR).
- Ethics and Compliance: Assessment of site adherence to Good Clinical Practice (GCP) guidelines and ethical standards.
Enhanced Site Performance Metrics: Our independent evaluation focuses on site performance metrics, providing a clear picture of each site's capabilities:
- Past Performance: Analysis of previous trial performance, including patient enrolment rates, retention, and data quality.
- Operational Capabilities: Assessment of the site's ability to meet trial timelines and requirements.
- Risk Management: Identification and mitigation of potential risks associated with site selection.
Key Services
- Customized Feasibility Reports: We deliver tailored feasibility reports to support your decision-making process. Our reports include:
- Detailed Findings: Comprehensive overview of site audits, assessments, including strengths and weaknesses.
